Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation Plans (Tables)

v3.22.4
Stock-Based Compensation Plans (Tables)
12 Months Ended
Jan. 28, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
Total stock-based compensation expense was recorded in the accompanying consolidated income statements as follows:
  Year Ended
  January 28, January 29, January 30,
(in millions) 2023 2022 2021
Cost of sales $ 19.7  $ 18.3  $ 15.4 
Selling, general and administrative expenses 90.7  61.6  68.5 
Total stock-based compensation expense $ 110.4  $ 79.9  $ 83.9 
Excess tax benefit (deficit) on stock-based compensation
    recognized in the Provision for income taxes
$ 9.8  $ 8.5  $ (2.8)
Schedule of Restricted Stock Units Activity
The following table summarizes the status of service-based RSUs as of January 28, 2023 and changes during the year then ended: 
Number of Shares Weighted Average Grant Date Fair Value
Nonvested at January 29, 2022
1,096,066  $ 94.16 
Granted 468,929  158.05 
Vested (546,036) 94.24 
Forfeited (150,239) 120.72 
Nonvested at January 28, 2023
868,720  $ 123.99 
Schedule of Nonvested Performance-based Units Activity
The following table summarizes the status of PSUs as of January 28, 2023 and changes during the year then ended: 
Number of Shares Weighted Average Grant Date Fair Value
Nonvested at January 29, 2022
584,972  $ 91.86 
Granted 206,044  159.57 
Vested (445,912) 99.87 
Forfeited (190,281) 116.61 
Nonvested at January 28, 2023
154,823  $ 125.84 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The assumptions used in the Black-Scholes option pricing model for this award are as follows:
Expected term (in years) 6.5
Expected stock price volatility 34.1  %
Dividend yield —  %
Risk-free interest rate 2.15  %
Schedule of Stock Option Activity
The following tables summarize information about options outstanding at January 28, 2023 and changes during the year then ended:
  Number of Shares Weighted Average Per Share Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value
(in millions)
Outstanding at January 29, 2022
24,541  $ 90.38     
Granted 2,252,979  157.17     
Exercised (583) 76.95     
Outstanding at January 28, 2023
2,276,937  $ 156.46  9.1 $ 1.4 
Exercisable at January 28, 2023
24,350  $ 90.92  3.8 $ 1.4